Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin

[1]  Brittany N. Lasseigne,et al.  Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.

[2]  T. Wieland,et al.  Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia , 2015, Nature Neuroscience.

[3]  J. Trojanowski,et al.  Variants associated with Gaucher disease in multiple system atrophy , 2015, Annals of clinical and translational neurology.

[4]  G. Nicholson,et al.  Analysis of dynein intermediate chains, light intermediate chains and light chains in a cohort of hereditary peripheral neuropathies , 2014, neurogenetics.

[5]  S. Myers,et al.  Mutations in the SPTLC1 protein cause mitochondrial structural abnormalities and endoplasmic reticulum stress in lymphoblasts. , 2014, DNA and cell biology.

[6]  I. Blair,et al.  Mutant Human FUS Is Ubiquitously Mislocalized and Generates Persistent Stress Granules in Primary Cultured Transgenic Zebrafish Cells , 2014, PloS one.

[7]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[8]  Adriano Chiò,et al.  State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.

[9]  Robert H. Brown,et al.  ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. , 2013, American journal of human genetics.

[10]  Olubunmi Abel,et al.  Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD) , 2013, JMIR mHealth and uHealth.

[11]  K. Williams,et al.  Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.

[12]  K. Mathews,et al.  Re‐analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation , 2013, Muscle & nerve.

[13]  G. Crabtree,et al.  Exome sequencing to identify de novo mutations in sporadic ALS trios , 2013, Nature Neuroscience.

[14]  S. Züchner,et al.  A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene. , 2013, Human molecular genetics.

[15]  T. Maniatis,et al.  Crystal structure and mechanism of activation of TANK-binding kinase 1. , 2013, Cell reports.

[16]  W. Hahn,et al.  Structure and ubiquitination-dependent activation of TANK-binding kinase 1. , 2013, Cell reports.

[17]  M. Swash,et al.  Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.

[18]  J. Lupski,et al.  A Loss‐of‐Function Variant in the Human Histidyl‐tRNA Synthetase (HARS) Gene is Neurotoxic In Vivo , 2013, Human mutation.

[19]  Joaquín Dopazo,et al.  Qualimap: evaluating next-generation sequencing alignment data , 2012, Bioinform..

[20]  M. Ryan,et al.  A family with 2 X‐linked disorders: Charcot‐Marie‐Tooth disease and hemophilia A , 2012, Muscle & nerve.

[21]  Leonard H van den Berg,et al.  Evidence for an oligogenic basis of amyotrophic lateral sclerosis. , 2012, Human molecular genetics.

[22]  N. Luquin,et al.  A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[23]  S. Tsuji,et al.  The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. , 2012, American journal of human genetics.

[24]  S. Tsuji,et al.  Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. , 2012, Archives of neurology.

[25]  Mark Latt,et al.  “Dancing feet dyskinesias”: A clue to parkin gene mutations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[26]  H. Hakonarson,et al.  Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. , 2012, Human molecular genetics.

[27]  Kelly L. Williams,et al.  Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[28]  R. Ritch,et al.  Confirmation of TBK1 duplication in normal tension glaucoma. , 2012, Experimental eye research.

[29]  I. Blair,et al.  Molecular genetics and mechanisms of disease in distal hereditary motor neuropathies: insights directing future genetic studies. , 2011, Current molecular medicine.

[30]  G. Superti-Furga,et al.  Functional Dissection of the TBK1 Molecular Network , 2011, PloS one.

[31]  A. Mes-Masson,et al.  KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. , 2011, American journal of human genetics.

[32]  M. Ryan,et al.  A retrospective review of X-linked Charcot-Marie-Tooth disease in childhood , 2011, Neurology.

[33]  Liang Xu,et al.  [Is normal-tension glaucoma different from primary open-angle glaucoma]. , 2011, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[34]  Nancy F. Hansen,et al.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. , 2010, American journal of human genetics.

[35]  I. Blair,et al.  TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. , 2010, The international journal of biochemistry & cell biology.

[36]  I. Blair,et al.  Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. , 2010, The international journal of biochemistry & cell biology.

[37]  G. Nicholson,et al.  Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies , 2010, Journal of Clinical Neuroscience.

[38]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[39]  K. Flanigan,et al.  Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy , 2010, Neuromuscular Disorders.

[40]  T. Ferguson,et al.  Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. , 2010, American journal of human genetics.

[41]  G. Nicholson,et al.  X-linked CMT: genes and gene loci in an Australian cohort , 2010, neurogenetics.

[42]  T. Hornemann,et al.  Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦ , 2010, The Journal of Biological Chemistry.

[43]  M. Kiernan,et al.  Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  M. Kiernan,et al.  FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  K. Williams,et al.  A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  S. Züchner,et al.  Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. , 2009, Brain : a journal of neurology.

[47]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[48]  T. Hornemann,et al.  A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated , 2009, neurogenetics.

[49]  H. Shill,et al.  The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study , 2008, BMC medicine.

[50]  J. Pollard,et al.  Histopathological Findings in Hereditary Motor and Sensory Neuropathy of Axonal Type With Onset in Early Childhood Associated With Mitofusin 2 Mutations , 2008, Journal of neuropathology and experimental neurology.

[51]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[52]  P. Schofield,et al.  Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9 , 2008, BMC neurology.

[53]  T. Gillis,et al.  Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[54]  H. Shill,et al.  Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.

[55]  A. Antonellis,et al.  Evidence of a founder haplotype refines the X-linked Charcot–Marie-Tooth (CMTX3) locus to a 2.5 Mb region , 2008, neurogenetics.

[56]  M. Ryan,et al.  Autosomal dominant congenital spinal muscular atrophy – A possible developmental deficiency of motor neurones? , 2008, Neuromuscular Disorders.

[57]  Christine Klein,et al.  Replication of association between ELAVL4 and Parkinson disease: the GenePD study , 2008, Human Genetics.

[58]  M. Kiernan,et al.  Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. , 2008, Brain : a journal of neurology.

[59]  J. Vallat,et al.  Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations , 2008, Neurology.

[60]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[61]  S. Tsuji,et al.  Asian origin for the worldwide-spread mutational event in Machado-Joseph disease. , 2007, Archives of neurology.

[62]  M. Shy,et al.  Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. , 2007, Archives of neurology.

[63]  K. Claeys,et al.  Hereditary spastic paraplegia 3A associated with axonal neuropathy. , 2007, Archives of neurology.

[64]  M. Ryan,et al.  Establishment of the Australasian paediatric Charcot-Marie-Tooth disease registry , 2007, Neuromuscular Disorders.

[65]  I. Blair,et al.  A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36 , 2007, Human Genetics.

[66]  M. MacDonald,et al.  Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age , 2006, Neurology.

[67]  G. Nicholson,et al.  Proof of genetic heterogeneity in X-linked Charcot–Marie–Tooth disease , 2006, Neurology.

[68]  S. Love,et al.  Late-onset hereditary sensory neuropathy type I due to SPTLC1 mutation: Autopsy findings , 2006, Clinical Neurology and Neurosurgery.

[69]  S. Züchner,et al.  G.O. 9 Dynamin 2 mutations are associated with dominant intermediate Charcot-Marie-Tooth disease and dominant centronuclear myopathy , 2006, Neuromuscular Disorders.

[70]  T. Gillis,et al.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.

[71]  G. Nicholson The dominantly inherited motor and sensory neuropathies: Clinical and molecular advances , 2006, Muscle & nerve.

[72]  S. Myers,et al.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. , 2006, Neuromolecular medicine.

[73]  H. Shill,et al.  BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study , 2005, Neurology.

[74]  J. Pollard,et al.  Autosomal dominant hereditary sensory neuropathy with chronic cough and gastro-oesophageal reflux: clinical features in two families linked to chromosome 3p22-p24. , 2005, Brain : a journal of neurology.

[75]  K. Fischbeck,et al.  Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. , 2005, Brain : a journal of neurology.

[76]  A. Kochański,et al.  Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci , 2005, Neurology.

[77]  Danqing Zhu,et al.  Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease , 2005, Nature Genetics.

[78]  G. Nicholson,et al.  AGE DEPENDENT PENETRANCE OF THREE DIFFERENT SUPEROXIDE DISMUTASE 1 (SOD 1) MUTATIONS , 2005, The International journal of neuroscience.

[79]  I. Dedova,et al.  Hypoxia Causes Aggregation of Serine Palmitoyltransferase followed by Non-Apoptotic Death of Human Lymphocytes , 2004, Cell cycle.

[80]  S. Myers,et al.  Transcript map of the candidate region for HSNI with cough and gastroesophageal reflux on chromosome 3p and exclusion of candidate genes , 2004, Neurogenetics.

[81]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[82]  I. Dedova,et al.  Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells. , 2004, Biochimica et biophysica acta.

[83]  Erdahl T. Teber,et al.  Tau haplotypes regulate transcription and are associated with Parkinson's disease , 2004, Annals of neurology.

[84]  I. Dedova,et al.  Equilibrium Between Cell Division and Apoptosis in Immortal Cells as an Alternative to the G1 Restriction Mechanism in Mammalian Cells , 2004, Cell cycle.

[85]  J. Pollard,et al.  A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24. , 2003, American journal of human genetics.

[86]  I. Dedova,et al.  Inhibition of topoisomerase II overrides the G2/M check points of the cell cycle in EBV-lymphocytes , 2003, Apoptosis.

[87]  Hanns Lochmüller,et al.  Mutation screening of the N‐myc downstream‐regulated gene 1 (NDRG1) in patients with Charcot‐Marie‐Tooth Disease , 2003, Human mutation.

[88]  J. Pollard,et al.  Peripheral neuropathies of infancy. , 2003, Developmental medicine and child neurology.

[89]  M. Verheijen,et al.  Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region , 2003, Neurogenetics.

[90]  H. Hartung,et al.  Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review. , 2003, Archives of neurology.

[91]  S. Vucic,et al.  CMT with pyramidal features , 2003, Neurology.

[92]  S. Brahmbhatt,et al.  Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy , 2002, Neuromuscular Disorders.

[93]  G. Nicholson,et al.  Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[94]  H. Hartung,et al.  Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? , 2002, Brain : a journal of neurology.

[95]  G. Nicholson,et al.  Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion , 2002, Movement disorders : official journal of the Movement Disorder Society.

[96]  R. Ritch,et al.  Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin , 2002, Science.

[97]  E. Storey,et al.  A new autosomal dominant pure cerebellar ataxia , 2001, Neurology.

[98]  S. Robertson,et al.  Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. , 2001, American journal of human genetics.

[99]  S. Brahmbhatt,et al.  Hereditary sensory neuropathy type I: haplotype analysis shows founders in southern England and Europe. , 2001, American journal of human genetics.

[100]  S. Brahmbhatt,et al.  Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I , 2001, Nature Genetics.

[101]  C. Masters,et al.  Variable phenotype of Alzheimer's disease with spastic paraparesis , 2001, Journal of neurochemistry.

[102]  J. Pollard,et al.  Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[103]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[104]  M. Bissell Development of a Multiplex Ligation-Dependent Probe Amplification Assay for Diagnosis and Estimation of the Frequency of Spinocerebellar Ataxia Type 15 , 2010 .

[105]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[106]  K. Refshauge,et al.  Night splinting does not increase ankle range of motion in people with Charcot-Marie-Tooth disease: a randomised, cross-over trial. , 2006, The Australian journal of physiotherapy.

[107]  M. Ryan,et al.  Dominant congenital non progressive motor neuron disorder , 2006 .

[108]  G. Nicholson,et al.  A rapid and definitive test for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies using multiplexed real-time PCR. , 2003, Genetic testing.

[109]  G. Halliday,et al.  Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. , 2001, Annals of neurology.